TAMPA, Fla., Jan. 19, 2022 /PRNewswire/ -- Hoyer Law Group is proud to announce that MD Labs, Inc., along with two of its owners, will pay up to $16 million to settle allegations that MD Labs submitted false laboratory claims for payment to Medicare, Medicaid, and other federal health care programs.
According to the settlement agreement, MD Labs and its owners regularly billed federal health care programs for medically unnecessary urine drug testing (UDT). MD Labs performed two types of UDT: presumptive testing, a relatively inexpensive test providing quick qualitative results, and confirmatory testing, an expensive test designed to confirm quantitatively the results of presumptive UDT. MD Labs performed both types of tests at approximately the same time and then simultaneously submitted the results to health care providers. The settlement highlights that the presumptive UDT results were frequently useless and the confirmatory UDT results typically baseless.
"MD Labs… billed Medicare and other federal health care programs for wasteful urine drug testing," said Acting United States Attorney Nathaniel R. Mendell. "They diverted valuable resources away from federal health care programs for expensive testing that was unnecessary. That kind of behavior will always get our attention."
"The American people reasonably expect our government to be good stewards of taxpayer funds, including investigating those who try to defraud taxpayer-supported public health programs such as...
The SEC is accusing a Florida fund manager of pocketing seven times his allowed fees and misrepresenting investment holdings to mislead investors. In a complaint filed in the Middle District of Fl...